HYDROXYCARBAMIDE MEDICIANZ hydroxycarbamide (hydroxyurea) 500 mg capsule blister

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

hydroxycarbamide (hydroxyurea), Quantity: 500 mg

Available from:

Medsurge Pharma Pty Ltd

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: erythrosine; magnesium stearate; titanium dioxide; Gelatin; indigo carmine; lactose monohydrate; quinoline yellow; dibasic sodium phosphate; citric acid; sodium lauryl sulfate

Administration route:

Oral

Units in package:

100, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Significant tumour response to hydroxycarbamide (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

Product summary:

Visual Identification: Size 0 hard gelatin capsules with an opaque pink body and an opaque light green cap containing a white to off-white homogeneous powder.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2020-06-03